Country

Merz Americas CEO Bob Rhatigan Joins Distinguished Life Sciences Leaders as a PharmaVOICE 100 Award Recipient

PharmaVOICE magazine announces most inspiring and influential leaders for its 2019 PharmaVOICE 100 awards

Today Merz announced Bob Rhatigan, CEO of Merz Americas, has been named one of the top 100 most inspiring and influential life sciences leaders by PharmaVOICE magazine, a premiere health care trade publication.

The annual PharmaVOICE 100 awards recognize inspirational, motivational and transformative individuals in life sciences who positively impact their colleagues, peers, organizations and the industry. Rhatigan is receiving this coveted award for his demonstrated ability to forge new markets in the medical aesthetics industry, launch disruptive, first-of-their-kind customer-centric campaigns, and champion women’s empowerment and inclusion.

“Bob operates with passion, humility and respect for others, always searching and finding those skills and talents to help individuals maximize their potential,” said Wm. Philip Werschler, M.D., founding member of Spokane Dermatology Clinic and Werschler Aesthetics. “He is unfailingly kind, even when the circumstances are difficult. It has been a pleasure to work with him for many years and I can think of no one more deserving of this honor.”

With more than two decades of experience in the medical aesthetics industry, Rhatigan is reshaping and expanding the market with his creativity, innovation, vision and drive. Since joining Merz in 2017, the organization has experienced unprecedented growth within its portfolio of medical aesthetic injectables, devices and skincare products. The culture Rhatigan created has inspired many top health care leaders to join Merz Americas, where more than half of management positions are filled by women.

“When I joined Merz, I stepped into a culture that acknowledged the differences for men and women in the workplace, and with Bob’s leadership, is actively working to be part of the solution,” said Terri L. Phillips, M.D., Vice President and Global Head of Medical Affairs at Merz. “This stems from Bob’s philosophy of ‘your success is our success.’ He works to make achievement contagious. He works for the good of every one in the company.”

PharmaVOICE 100 award recipients are nominated by PharmaVOICE readers and are evaluated by a comprehensive submission process including peer essays. Winners will be honored at the fifth annual PharmaVOICE 100 celebration taking place in New York City this September.

“I am honored to receive this recognition from PharmaVOICE,” said Bob Rhatigan, CEO of Merz Americas. “As a go-to source for pharmaceutical industry news, I am humbled to be part of the PharmaVOICE 100 Class of 2019. Thank you to my family, colleagues and mentors who have encouraged and supported me throughout the years.”

Contact:
Jane Yarbrough
Corporate Communications
Merz Americas
Jane.Yarbrough@merz.com
(984) 218-0983

Press Contact

Merz North America

Emily Browder
Corporate Communications

 

Phone: +1 919.582.8114

Merz in the Americas

Merz has a direct presence in six countries in the Americas, as well as a network of selected professional distribution partners in South and Central America and the Caribbean. Merz in the Americas is headquartered in Raleigh, North Carolina, and has facilities in Mesa, Arizona, Franksville, Wisconsin as well as offices in Toronto, Canada, Mexico City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina.

Merz Worldwide

With approximately 3,000 employees and a direct presence in 28 countries, Merz is a global, family-owned aesthetics and neurotoxin company based in Frankfurt, Germany. Privately held for 110 years, the company is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In addition to its comprehensive portfolio of medical aesthetic products in the device, injectable and skincare categories, Merz also develops neurotoxin therapy to treat neurologically-induced movement disorders. In fiscal year 2016/17, Merz generated revenue of EUR 1,092.9 million. More information is available at www.merz.com.

Media Contact – Global

Merz Pharma GmbH & Co. KGaA
Global Corporate Communications
Mariana Smith Bourland
Phone: +49 151 4249 1466
Email: mariana.smith@merz.com

Media Contact – North America

Merz North America, Inc.
Corporate Communications
Emily Browder
Phone: +1 919.582.8114
Email: Emily.Browder@merz.com